Article Details

AstraZeneca Pharma India challenges NPPA's demand notice in Delhi High Court

Retrieved on: 2021-06-29 15:11:15

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Pharma India challenges NPPA's demand notice in Delhi High Court. View article details on hiswai:

Excerpt

Shares of AstraZeneca Pharma India closed at Rs 3,621.10 per scrip on BSE, down 0.80 per cent from its previous close. PTI. Jun 29, ...

Article found on: www.businesstoday.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up